Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes - Creely, S. J; McTernan, P. G; Kusminski, C. M; Fisher, ff. M; Da Silva, N. F; Khanolkar, M; Evans, M; Harte, A. L; Kumar, S (American journal of physiology: endocrinology and metabolism, 2007)
Keywords: Adipocytes, White - drug effects; Adipocytes, White - immunology; Adipocytes, White - metabolism; Adipose tissue; Adult; Aged; Cells; Cells, Cultured; Cytokines; Diabetes; Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - immunology; Diabetes Mellitus, Type 2 - pathology; Female; Health risks; Humans; Immune response; Immune system; Immunity, Innate - drug effects; Inflammatory diseases; Insulin; Lipopolysaccharides - pharmacology; Male; Middle Aged; Myeloid Differentiation Factor 88 - metabolism; NF-kappa B - antagonists & inhibitors; Obesity - blood; Obesity - immunology; Obesity - pathology; Subcutaneous Fat, Abdominal - drug effects; Subcutaneous Fat, Abdominal - immunology; Subcutaneous Fat, Abdominal - metabolism; Tissues; TNF Receptor-Associated Factor 6 - metabolism; Toll-Like Receptors - metabolism